These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2754297)

  • 1. Ophthalmic epinephrine, phenylephrine, and pilocarpine affect the systemic absorption of ocularly applied timolol.
    Urtti A; Kyyrönen K
    J Ocul Pharmacol; 1989; 5(2):127-32. PubMed ID: 2754297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of epinephrine pretreatment and solution pH on ocular and systemic absorption of ocularly applied timolol in rabbits.
    Kyyrönen K; Urtti A
    J Pharm Sci; 1990 Aug; 79(8):688-91. PubMed ID: 2231330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular drug interactions involving topically applied timolol in the pigmented rabbit.
    Luo AM; Sasaki H; Lee VH
    Curr Eye Res; 1991 Mar; 10(3):231-40. PubMed ID: 2044391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.
    Järvinen K; Urtti A
    J Ocul Pharmacol; 1992; 8(2):91-8. PubMed ID: 1506759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
    Lee VH; Luo AM; Li SY; Podder SK; Chang JS; Ohdo S; Grass GM
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac effects of different eyedrop preparations of timolol in rabbits.
    Järvinen K; Urtti A
    Curr Eye Res; 1992 May; 11(5):469-73. PubMed ID: 1606842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
    Korte JM; Kaila T; Saari KM
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption.
    Chang SC; Lee VH
    J Ocul Pharmacol; 1987; 3(2):159-69. PubMed ID: 3503911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic absorption of ocular timolol in poor and extensive metabolizers of debrisoquine.
    Huupponen R; Kaila T; Lahdes K; Salminen L; Iisalo E
    J Ocul Pharmacol; 1991; 7(2):183-7. PubMed ID: 1919275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic absorption of topically applied ocular timolol.
    Kaila T; Salminen L; Huupponen R
    J Ocul Pharmacol; 1985; 1(1):79-83. PubMed ID: 3880069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits.
    Burgalassi S; Chetoni P; Panichi L; Saettone MF
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):1-7. PubMed ID: 10048342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure reduction and systemic absorption of timolol after administration of one side-coated inserts in rabbits.
    Saettone MF; Chetoni P; Cappanera L; Conte U; Finne U; Järvinen K; Salivirta J; Urtti A
    J Ocul Pharmacol; 1993; 9(1):1-12. PubMed ID: 8463729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topical glaucoma drugs on fistulized rabbit conjunctiva.
    Young TL; Higginbotham EJ; Zou XL; Farber MD
    Ophthalmology; 1990 Nov; 97(11):1423-7. PubMed ID: 2255514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the ocular to systemic ratio of topical timolol by varying the dosing time.
    Ohdo S; Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2790-8. PubMed ID: 1894477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.
    Urtti A; Rouhiainen H; Kaila T; Saano V
    Pharm Res; 1994 Sep; 11(9):1278-82. PubMed ID: 7816756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
    Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
    Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evaluation of a new timolol/pilocarpine formulation.
    Bucolo C; Spadaro A; Mangiafico S
    Ophthalmic Res; 1998; 30(2):101-6. PubMed ID: 9523288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ocular blood flow of cats after local administration of pilocarpine, phenylephrine, and of a mixture of both drugs (author's transl)].
    Kaskel D; Spangenberg U; Rudolf H; Hübel H; Witt N; Baumgart W
    Klin Monbl Augenheilkd; 1978 Mar; 172(3):356-63. PubMed ID: 633770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol.
    Chang SC; Chien DS; Bundgaard H; Lee VH
    Exp Eye Res; 1988 Jan; 46(1):59-69. PubMed ID: 3342834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.